All India Chemists and Druggists association urges members to ensure adequate stock supplies in border states

[ad_1] New Delhi: The All India Organization of Chemists and Druggists (AIOCD) have directed all its 1.2 million members, particularly, stockists, wholesalers and retailers to maintain adequate stocks life-saving drugs and pharmaceutical items in border states. Also Read | Trump’s drug-price cut plan triggers share drop: Will Indian pharma be impacted? AIOCD has asked its…

Read More

US-India trade talks: Steer clear of deal-breakers

[ad_1] Although these are early days in the negotiations for a multi-sectoral bilateral trade agreement (BTA) between India and the US, the final outcome is already being envisaged as the ‘mother of all deals’ and a ‘grand trade deal.’ Both countries are expected to negotiate hard for finalizing an agreement that maximizes benefits for their…

Read More

Govt floats EOI for doing major Research & Development in pharma medtech sector and drugs

[ad_1] New Delhi: The government has sought expressions of interest (EoI) for research & development (R&D) projects to develop novel technologies in medicine, including medical devices and drugs for communicable and non-communicable diseases. The focus will be on drug discovery for hypertension, lung disease, cancer, diabetes and rare diseases. The EoIs have been floated by…

Read More

Over 100 MSME drug firms modernizing their pharma unit as per WHO standards

[ad_1] New Delhi: A total of 103 applications have been approved for Central financial assistance to MSME (micro, small and medium enterprises) drug firms wishing to upgrade to international standards, the government said, addressing an impediment to India’s pharma export ambitions. The total financial support under the government’s revamped Pharmaceutical Technology Upgradation Assistance Scheme amounted…

Read More

Indian hospitals cast wider net to cope with unexpected casualty of Bangladesh crisis: Medical tourism

[ad_1] Bangladeshi patients make up the largest chunk of international visitors checking into Indian hospitals for procedures, but numbers dipped sharply last year after political crisis gripped the neighbouring country. While hospitals like Apollo and Manipal–which were among the most impacted – are expecting a gradual uptick, the focus is now on bringing in more…

Read More

Kiran Mazumdar Shaw-backed Immuneel rolls out CAR-T cancer therapy in India today, will focus on affordability

[ad_1] The startup, co-founded by Kiran Mazumdar-Shaw, was the first company in India to conduct CAR T-cell therapy trials in 2022. The therapy, called Qartemi, is used to treat adult B-cell non-hodgkin lymphoma, and has been licensed from the Hospital ClĂ­nic de Barcelona (HCB) of Spain. CAR T-cell therapy involves genetically engineering a patient’s T…

Read More
Back To Top